Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Calidi Biotherapeutics (CLDI) Long-Term Debt Issuances (2022 - 2024)

Calidi Biotherapeutics' quarterly Long-Term Debt Issuances came in at -$2.8 million in Q4 2024, down 200.0% quarter-over-quarter from $2.8 million in Q3 2024.

Calidi Biotherapeutics has reported Long-Term Debt Issuances for 3 years, with the latest figure at -$2.8 million in Q4 2024.

  • For the quarter ending Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Dec 2024 stood at $200000.0 (down 84.0% YoY), and the FY2024 full-year result was $200000.0, down 84.0% from the prior year.
  • Long-Term Debt Issuances for Q4 2024 stood at -$2.8 million, down from $2.8 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $3.0 million in Q1 2024, with the low at -$2.8 million in Q2 2024.
  • Average Long-Term Debt Issuances over 3 years is $243750.0, with a median of $625000.0 recorded in 2023.
  • Peak annual rise in Long-Term Debt Issuances reached 300.0% in 2024, while the deepest fall reached 660.0% in 2024.
  • Tracing CLDI's Long-Term Debt Issuances over 3 years: stood at -$1.9 million in 2022, then surged by 126.32% to $500000.0 in 2023, then tumbled by 660.0% to -$2.8 million in 2024.
  • The last three Long-Term Debt Issuances figures came in at -$2.8 million (Q4 2024), $2.8 million (Q3 2024), and -$2.8 million (Q2 2024), per Business Quant data.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -2.80 Mn
Dec 31, 2024 -2.80 Mn
Sep 30, 2024 2.80 Mn
Sep 30, 2024 2.80 Mn
Jun 30, 2024 -2.80 Mn
Jun 30, 2024 -2.80 Mn
Mar 31, 2024 3.00 Mn
Mar 31, 2024 3.00 Mn
Jun 30, 2023 500,000.00
Jun 30, 2023 500,000.00
Mar 31, 2023 750,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 -1.90 Mn
Dec 31, 2022 -1.90 Mn
Sep 30, 2022 2.40 Mn
Sep 30, 2022 2.40 Mn